Evidence map›Paper›PMID 38390538›Full record

ArticleIndian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India

Comparison of Diagnostic Value between

Mohsen Alemi, Farshad Banouei, Reyhaneh Ahmadi

Abstract read
In one paragraph

Article in Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Diagnostic efficacy of [BMC cancer · 2024
    Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mohsen AlemiUrology and Nephrology Research Center, Hamedan University of Medical Sciences, Hamedan, Iran.
Farshad BanoueiUrology and Nephrology Research Center, Hamedan University of Medical Sciences, Hamedan, Iran.
Reyhaneh AhmadiDepartment of Nuclear Medicine, School of Medicine, Hamedan University of Medical Sciences, Hamedan, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Prostate cancer (PCa) ranks as the second most prevalent cancer among men globally. The utilization of efficient and cost-effective diagnostic and therapeutic approaches holds paramount importance in the diagnosis and treatment of these patients, significantly impacting treatment outcomes. This study focuses on the investigation and comparison of two commonly employed scans within the treatment process for these patients. Methods: In this prospective study, which spanned over 2 years, 40 patients diagnosed with PCa underwent examination using two scans: Results: In this prospective study, the sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of the Conclusions: Based on the findings of this study, it can be concluded that the diagnostic accuracy of the

Indexed as

99mTechnetium-methylene diphosphate bone scan99mtechnetium-prostate-specific membrane antigen scanprostate cancer

Identifiers

PMID38390538
PMCPMC10880839

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.